摘要
目的观察百令胶囊治疗早期糖尿病肾病的临床疗效。方法 40例早期糖尿病肾病患者,随机分为观察组和对照组各20例。均给予常规药物厄贝沙坦治疗,观察组给予百令胶囊治疗,8周后评价临床效果。结果 8周后与对照组比较,观察组24 h尿白蛋白定量下降,差异有统计学意义(P <0. 05)。结论百令胶囊可有效减少尿蛋白,对于早期糖尿病肾病具有良好治疗效果。
Objective To observe the clinical effect of Bailing capsules on early diabetic nephropathy.Methods Forty patients with early diabetic nephropathy were randomly divided into observation group and control group,with 20 cases in each group. Both the observation group and the control group were treated with conventional drug irbesartan,and the observation group was treated with Bailing capsules. The clinical effects of the two groups were evaluated 8 weeks after treatment. Results Compared with that in the control group,the 24-hour urinary albumin quantification was significantly decreased in the observation group 8 weeks after treatment( P < 0. 05). Conclusion Bailing capsules can reduce urinary albumin and have a good clinical effect on early diabetic nephropathy.
作者
栗娜
LI Na(Community Health Service Center of Dongcheng District of Beijing City,Beijing 100010,China)
出处
《中国临床新医学》
2019年第3期308-310,共3页
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
关键词
百令胶囊
糖尿病肾病
临床疗效
Bailing capsules
Diabetic nephropathy
Clinical efficacy
